Machine Learning based Modeling of Drugs using Virtual Screening and in Silico Approach

The process and implementation of drug development is a complex structure which is a time-consuming process with higher accuracy. A transformative approach to optimize drug discovery is achieved through the integration of drug discovery with a virtual screening process. This is implemented through the in silico machine learning process. The traditional methods involve extracting and testing numerous chemical compounds in vitro and in vivo in the identification of potential drug contenders. These methods lead to various drawbacks that include higher costs with timelines. To overcome the drawbacks of the existing system, the integration of paradigm modeling is initiated. The behavior of molecules with biological targets is determined through In-silico machine learning algorithms. The effective analysis of millions of chemical compounds is done using a virtual screening process through computational simulations and desired pharmacological effects. The machine learning algorithms help in the extraction of intricate patterns from the molecular dataset. Certain properties such as molecule binding affinity, bioavailability, and toxicity are predicted using these algorithms. They help to optimize the molecular structure in silico to improve the interaction with the target proteins. The reliability is achieved through the quality of the training data with the robustness of the algorithm. They help to generalize newer chemical combinations that provide the solution for various diseases with personalized recommendations through the aid of artificial intelligence.